ChristopherRChitambarMD

Professor of Medicine, Medical College Wisc

Dr. Chitambar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
9200 W Wisconsin Ave
# Division
Milwaukee, WI 53226
Phone+1 414-805-6800

Fax+1 414-805-4944

University of ColoradoFellowship, Hematology and Medical Oncology, 1980 - 1983
University of Texas at Austin Dell Medical SchoolResidency, Internal Medicine, 1978 - 1980
University of Texas at Austin Dell Medical SchoolInternship, Transitional Year, 1977 - 1978
Christian Medical College LudhianaClass of 1976

America's Top Doctors Castle Connolly, 2004-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Redbook Magazine: Top Breast Cancer Doctors Castle Connolly, 2001
Fellow (FACP) American College of Physicians, 1999
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Whos Who in Medicine and Healthcare Marquis Whos Who
Join now to see all

PubMed

2 citations
Stay on Track: A Pilot Randomized Control Trial on the Feasibility of a Diet and Exercise Intervention in Patients with Breast Cancer Receiving Radiotherapy.
Gopika SenthilKumar, Aronne M Schottstaedt, Lindsay L Peterson, Lauren N Pedersen, Christopher R Chitambar
Cancer Research Communications. 2024-05-07
Divergent Cellular Expression Patterns of PD-L1 and PD-L2 Proteins in Breast Cancer.
Julie M Jorns, Yunguang Sun, Sailaja Kamaraju, Yee Chung Cheng, Amanda Kong
Journal of Personalized Medicine. 2024-04-29
Matched Case Control Analysis of Breast Cancer- Specific Factors Affecting Risk of Developing SARS-CoV-2 Infection.
Michael Pierro, Joanna Zurko, Anika Szabo, Yee Chung Cheng, Sailaja Kamaraju
WMJ. 2023-12-01

Imaging Biometrics Shares Promising Phase 1 Clinical Trial Results and Plans for Phase 2June 19th, 2024
Glioblastoma Clinical Trial Studying New Therapy Gallium Maltolate (GaM)April 12th, 2022
Innovative Therapy That “Tricks” and Destroys Cancer Cells Advances to Clinical TrialApril 8th, 2022
Join now to see all

Cellular Targets For Gallium Compounds In LymphomaNational Cancer Institute2005–2008
Gallium--Antineoplastic Activity And Drug ResistanceNational Cancer Institute1995–1997
Cellular Uptake And Interaction Of Iron And GalliumNational Cancer Institute1988–1992
Cellular Uptake And Interaction Of Iron And GalliumNational Cancer Institute1986–1988